Inspec

Inspec CROIC

The Cash Return on Invested Capital (CROIC) of Inspec (6656.T) as of Oct 21, 2026 is -17.53 %. In the previous year, Cash Return on Invested Capital (CROIC) was 17.45 % — a change of -200.47% (lower).

CROIC

-17.53 %

YoY

-200.47%

Last updated:

Cash Return on Invested Capital (CROIC) of Inspec is 2026 -17.53 % . Cash Return on Invested Capital (CROIC) of Inspec was 2025 17.45 % . It decreases by -200.47% lower compared to the previous year.

The Inspec CROIC history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

CROIC
Date
CROIC
Jan 1, 2019
20.88 JPY
Jan 1, 2020
-11.04 JPY
Jan 1, 2021
-13.30 JPY
Jan 1, 2022
-16.65 JPY
Jan 1, 2023
-20.02 JPY
Jan 1, 2024
0.57 JPY
Jan 1, 2025
17.45 JPY
Jan 1, 2026
-17.53 JPY
The Inspec CROIC history
YEARCROICYoY
-17.53 %-200.47%
17.45 %+2,967.45%
0.57 %-102.84%
-20.02 %+20.21%
-16.65 %+25.18%
-13.30 %+20.47%
-11.04 %-152.89%
20.88 %-192.33%
-22.61 %-246.43%
15.44 %+156.69%
6.02 %-185.07%
-7.07 %-65.69%
-20.61 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Inspec Stock analysis

What does Inspec do? inspec Inc. generates revenue through three primary segments. The Semiconductor Package Substrates and Precision Substrate Inspection Equipment segment sells appearance inspection equipment for semiconductor package substrates and precision printed circuit boards used in smartphones, tablets, PCs, and wearable terminals. The Precision Substrate Manufacturing Equipment segment provides photoplotters, inkjet printers, and direct imaging devices along with maintenance services for printed circuit boards. The Digital Pathology Related Equipment segment develops and sells medical image processing systems, specifically whole slide imaging (WSI) for digital pathology applications. Customers include manufacturers of advanced digital devices requiring semiconductor inspection, PCB producers needing photoplotters and imaging devices, and healthcare providers utilizing whole slide imaging systems for pathology diagnostics. The company's products target the semiconductor, electronics manufacturing, and medical imaging sectors with specific applications in device assembly, PCB production, and medical diagnostics. inspec Inc. focuses on equipment for semiconductor package substrates, precision substrates, and digital pathology, serving clients in the electronics and healthcare industries. The firm's inspection and imaging solutions are tailored to meet the quality control needs of high-tech manufacturing and medical diagnostics, with no mention of additional revenue streams beyond these three segments. Inspec is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Inspec stock

Cash Return on Invested Capital (CROIC) of Inspec is -17.53 % in 2026.

Cash Return on Invested Capital (CROIC) of Inspec changed from 17.45 % to -17.53 %, representing a -200.47% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Cash Return on Invested Capital (CROIC) Inspec since 2006 – with annual values, charts, and detailed analysis.

CROIC measures the cash return generated on invested capital. Unlike ROIC, it uses free cash flow instead of accounting earnings, providing a purer profitability measure.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Cash Return on Invested Capital (CROIC)'s Inspec with sector peers and the industry average to assess whether it is attractive.

To evaluate Cash Return on Invested Capital (CROIC)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Cash Return on Invested Capital (CROIC).

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Profitability — Inspec

All Key Metrics — Inspec